Cargando…

Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease

INTRODUCTION: Alzheimer’s disease (AD) is a neurodegenerative pathology that develops mainly in elderly and senile people. Disruption of BDNF transport or suppression of its production appears to be typical for people of old age. OBJECTIVES: Objective: To investigate the influence of Alzheimer’s dis...

Descripción completa

Detalles Bibliográficos
Autor principal: Sidenkova, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471910/
http://dx.doi.org/10.1192/j.eurpsy.2021.371
_version_ 1784789188196958208
author Sidenkova, A.
author_facet Sidenkova, A.
author_sort Sidenkova, A.
collection PubMed
description INTRODUCTION: Alzheimer’s disease (AD) is a neurodegenerative pathology that develops mainly in elderly and senile people. Disruption of BDNF transport or suppression of its production appears to be typical for people of old age. OBJECTIVES: Objective: To investigate the influence of Alzheimer’s disease on the secretion of brain factors and correlate with neuropsychological profiles. METHODS: 12 men (2) and women (10) with Alzheimer’s disease were examined. The average age of the subjects was 76.25 + 4.89. Methods: MMSE, ADAS-COG, laboratory - BDNF was performed using the G7611 BDNF Emax (R) ImmunoAssaySystem 5 x 96 wells, BDNF Emax® Immunological test. RESULTS: 2 patients have mild dementia, 8 patients have moderate dementia, 2 patients have severe dementia. The average age of patients with mild dementia was 72.0 + 1.0. The average MMSE score is 16.7 + 3.4. Correlation analysis showed a close relationship between a pronounced decrease in memory in memory tests (ADAS-COG) and a pronounced decrease in blood BDNF content (r = 0.676). A close statistically significant relationship was found between a low result of the recognition test and a low blood BDNF content (r = 0.598). CONCLUSIONS: we assume that blood BDNF is a marker of pathologically accelerated aging of the central nervous system, since low test results for mnestic function are an indicator of severe degeneration in Alzheimer’s disease DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9471910
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94719102022-09-29 Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease Sidenkova, A. Eur Psychiatry Abstract INTRODUCTION: Alzheimer’s disease (AD) is a neurodegenerative pathology that develops mainly in elderly and senile people. Disruption of BDNF transport or suppression of its production appears to be typical for people of old age. OBJECTIVES: Objective: To investigate the influence of Alzheimer’s disease on the secretion of brain factors and correlate with neuropsychological profiles. METHODS: 12 men (2) and women (10) with Alzheimer’s disease were examined. The average age of the subjects was 76.25 + 4.89. Methods: MMSE, ADAS-COG, laboratory - BDNF was performed using the G7611 BDNF Emax (R) ImmunoAssaySystem 5 x 96 wells, BDNF Emax® Immunological test. RESULTS: 2 patients have mild dementia, 8 patients have moderate dementia, 2 patients have severe dementia. The average age of patients with mild dementia was 72.0 + 1.0. The average MMSE score is 16.7 + 3.4. Correlation analysis showed a close relationship between a pronounced decrease in memory in memory tests (ADAS-COG) and a pronounced decrease in blood BDNF content (r = 0.676). A close statistically significant relationship was found between a low result of the recognition test and a low blood BDNF content (r = 0.598). CONCLUSIONS: we assume that blood BDNF is a marker of pathologically accelerated aging of the central nervous system, since low test results for mnestic function are an indicator of severe degeneration in Alzheimer’s disease DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9471910/ http://dx.doi.org/10.1192/j.eurpsy.2021.371 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Sidenkova, A.
Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease
title Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease
title_full Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease
title_fullStr Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease
title_full_unstemmed Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease
title_short Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease
title_sort correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471910/
http://dx.doi.org/10.1192/j.eurpsy.2021.371
work_keys_str_mv AT sidenkovaa correlationofneurotrophicandneuropsychologicalparametersinalzheimersdisease